{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:07Z","timestamp":1791357487623,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ajp.2022.103375","type":"journal-article","created":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T14:12:18Z","timestamp":1669471938000},"page":"103375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Pharmacological and nonpharmacological augmentation treatments for clozapine-resistant schizophrenia: A systematic review and network meta-analysis with normalized entropy assessment"],"prefix":"10.1016","volume":"79","author":[{"given":"Ta-Chuan","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Tao","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Sheng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae","family":"Il Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Nian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-5586","authenticated-orcid":false,"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2022.103375_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/NMD.0b013e3181be7422","article-title":"A preliminary controlled trial of cognitive behavioral therapy in clozapine-resistant schizophrenia","volume":"197","author":"Barretto","year":"2009","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ajp.2022.103375_bib2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1176\/ajp.153.12.1625","article-title":"Fluoxetine augmentation of clozapine treatment in patients with schizophrenia","volume":"153","author":"Buchanan","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2020.12.002","article-title":"Characteristics and definitions of ultra-treatment-resistant schizophrenia - a systematic review and meta-analysis","volume":"228","author":"Campana","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2022.103375_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brainresrev.2007.09.006","article-title":"The role of cortical inhibition in the pathophysiology and treatment of schizophrenia","volume":"56","author":"Daskalakis","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ajp.2022.103375_bib5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","article-title":"Dopamine synthesis capacity in patients with treatment-resistant schizophrenia","volume":"169","author":"Demjaha","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib6","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00004714-200110000-00005","article-title":"A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia","volume":"21","author":"Goff","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2022.103375_bib8","first-page":"18","article-title":"Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia","author":"Goldstein","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2022.103375_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S1461145708009085","article-title":"Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation","volume":"12","author":"Gray","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2022.103375_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib11","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.ajp.2022.103375_bib12","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1002\/sim.3427","article-title":"Meta-analysis of skewed data: combining results reported on log-transformed or raw scales","volume":"27","author":"Higgins","year":"2008","journal-title":"Stat. Med."},{"key":"10.1016\/j.ajp.2022.103375_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/JCP.0000000000000345","article-title":"Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms","volume":"35","author":"Kelly","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2022.103375_bib16","first-page":"213","article-title":"A comparison of the outlier detecting methods: an application on Turkish foreign trade data","volume":"5","author":"Kolba\u015fi","year":"2019","journal-title":"J. Math. Stat. Sci."},{"key":"10.1016\/j.ajp.2022.103375_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia","volume":"60","author":"Lane","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/npp.2008.200","article-title":"A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia","volume":"34","author":"Lieberman","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ajp.2022.103375_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.biopsych.2020.01.021","article-title":"Glutamate and dysconnection in the salience network: neurochemical, effective connectivity, and computational evidence in schizophrenia","volume":"88","author":"Limongi","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib20","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4088\/JCP.08m04935gry","article-title":"Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine","volume":"70","author":"de Lucena","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S2215-0366(18)30184-6","article-title":"Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial","volume":"5","author":"Morrison","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0269881110372548","article-title":"Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study","volume":"25","author":"Muscatello","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2022.103375_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/JCP.0b013e318248dfb8","article-title":"Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study","volume":"32","author":"Nielsen","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2022.103375_bib24","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1503\/jpn.210113","article-title":"Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels","volume":"47","author":"Ochi","year":"2022","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ajp.2022.103375_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.2014.13060787","article-title":"Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study","volume":"172","author":"Petrides","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.euroneuro.2011.08.005","article-title":"Clozapine resistance: augmentation strategies","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2022.103375_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103132","article-title":"Efficacy and safety of maintenance electroconvulsive therapy (M-ECT) in treatment-resistant schizophrenia: a case series","volume":"73","author":"Purohith","year":"2022","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2022.103375_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.clinph.2013.01.014","article-title":"A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders","volume":"124","author":"Radhu","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.ajp.2022.103375_bib29","first-page":"CD011847","article-title":"Electroconvulsive therapy for treatment-resistant schizophrenia","volume":"3","author":"Sinclair","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ajp.2022.103375_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0004867418772351","article-title":"Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis","volume":"52","author":"Siskind","year":"2018","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2013.09.038","article-title":"Review of the efficacy of transcranial magnetic stimulation for auditory verbal hallucinations","volume":"76","author":"Slotema","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib32","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2022.103375_bib33","first-page":"CD009555","article-title":"Clozapine dose for schizophrenia","volume":"6","author":"Subramanian","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ajp.2022.103375_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size-or why the p value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J. Grad. Med. Educ."},{"key":"10.1016\/j.ajp.2022.103375_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.2011.01792.x","article-title":"Augmentation of clozapine with a second antipsychotic - a meta-analysis","volume":"125","author":"Taylor","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2022.103375_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jrsm.46","article-title":"Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability","volume":"2","author":"Thorlund","year":"2011","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.ajp.2022.103375_bib37","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/M15-2521","article-title":"Uncertainty in treatment rankings: reanalysis of network meta-analyses of randomized trials","volume":"164","author":"Trinquart","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ajp.2022.103375_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.schres.2019.01.021","article-title":"Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine","volume":"208","author":"Wagner","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2022.103375_bib39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/schbul\/sbaa060","article-title":"Clozapine combination and augmentation strategies in patients with schizophrenia -recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group","volume":"46","author":"Wagner","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2022.103375_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2018.08.002","article-title":"ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials","volume":"105","author":"Wang","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ajp.2022.103375_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103189","article-title":"Intensive rTMS for treatment-resistant depression patients with suicidal ideation: an open-label study","volume":"74","author":"Wang","year":"2022","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2022.103375_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/0272989X21999023","article-title":"Using normalized entropy to measure uncertainty of rankings for network meta-analyses","volume":"41","author":"Wu","year":"2021","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ajp.2022.103375_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4088\/JCP.v66n0109","article-title":"A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety","volume":"66","author":"Ya\u011fcio\u011flu","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103375_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004850-200403000-00003","article-title":"The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study","volume":"19","author":"Zoccali","year":"2004","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822003732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822003732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:47:08Z","timestamp":1761756428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201822003732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"alternative-id":["S1876201822003732"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103375","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and nonpharmacological augmentation treatments for clozapine-resistant schizophrenia: A systematic review and network meta-analysis with normalized entropy assessment","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103375"}}